Evaluation of general condition before and after vitreous anti-VEGF drug administration for diabetic macular edema
Not Applicable
- Conditions
- Diabetic macular edema
- Registration Number
- JPRN-UMIN000044287
- Lead Sponsor
- Fukui University
- Brief Summary
Central retinal thickness and visual acuity significantly improved at three months and through-out the period after initiating therapy ; a significant change in HbA1c was not found. A total of 59.8% of patients became more active in glycemic control through exercise and diet therapy after initiating therapy, resulting in a significantly lower HbA1c at 6, 12, and 18 months compared to patients who did not.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 112
Inclusion Criteria
Not provided
Exclusion Criteria
Active endophthalmitis or infection in either eye, uncontrolled glaucoma in either eye, or a history of stroke.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method